(Press-News.org) (Toronto, May 6, 2024) A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended Reality–Enhanced Behavioral Activation for Adults With Major Depressive Disorder: Randomized Controlled Trial," the research, led by Dr Margot Paul and team from Stanford University, unveiled the effectiveness of extended reality (XR)–enhanced behavioral activation (XR-BA) in easing symptoms of depression.
MDD affects millions worldwide, and access to evidence-based psychotherapies remains a challenge for many. Traditional treatments often face barriers, prompting researchers to explore innovative solutions. XR, which includes VR, encompasses various immersive technologies involving computer-generated environments that blend physical and digital worlds. Leveraging the immersive power of XR, this study explored XR-BA as a potential game-changer in MDD treatment.
Dr Paul and team conducted a randomized controlled trial among 26 outpatients with MDD receiving remote care. Using a VR Meta Quest 2 headset, the participants engaged in simulated pleasant or mastery activities, including playing a magical VR board game, deciphering clues to solve puzzles, dancing to music, and playing mini golf alone or with friends. Though the learning curve for using the headset was high, participants reported that the experience became more enjoyable and useful over time.
The results were comparable to traditional behavioral activation delivered via telehealth. Both XR-BA and traditional behavioral activation helped reduce the severity of depression in a significant way, as measured by the Patient Health Questionnaire–9. Moreover, the findings suggest that individuals in the XR-BA group might have experienced a heightened expectancy or placebo response because of the novelty of the technology and implicit beliefs regarding mental health treatment.
"These results indicate that XR may help to de-stigmatize mental healthcare and reduce barriers to individuals seeking care. Clinicians could use XR as a treatment tool to help motivate clients to actively participate in their psychotherapy treatment by completing ‘homework’ that is novel, fun, and accessible," remarked Dr Paul.
The study underscores the potential of VR, particularly XR-BA, in revolutionizing depression treatment by offering efficacy akin to traditional therapy. This is a promising avenue for enhancing treatment outcomes and addressing barriers to accessing evidence-based psychotherapies for MDD, potentially expanding care for affected individuals. Additionally, the exploration of XR's capacity to amplify placebo effects hints at the transformative possibilities of technology-assisted mental health therapies.
Please cite as:
Paul M, Bullock K, Bailenson J, Burns D
Examining the Efficacy of Extended Reality–Enhanced Behavioral Activation for Adults With Major Depressive Disorder: Randomized Controlled Trial
JMIR Ment Health 2024;11:e52326
doi: 10.2196/52326
URL: https://mental.jmir.org/2024/1/e52326
###
About JMIR Publications:
JMIR Publications is a renowned publisher with a long-standing commitment to advancing digital health research and progressing open science. Our portfolio includes a wide array of prestigious open access, peer-reviewed journals dedicated to the dissemination of high-quality research in the field of digital health. JMIR Publications is celebrating its 25th anniversary in 2024 as the leading open access, digital health publisher.
To learn more about JMIR Publications, please visit jmirpublications.com or connect with us via Twitter, LinkedIn, YouTube, Facebook, and Instagram.
Head office: 130 Queens Quay East, Unit 1100, Toronto, ON, M5A 0P6 Canada
Media contact: communications@jmir.org
The content of this communication is licensed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, published by JMIR Publications, is properly cited.
END
Beyond therapy: Virtual reality shows promise in fighting depression
2024-05-06
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
How likely are English learners to graduate from high school? New study shows it depends on race, gender, and income
2024-05-06
English learners are, on average, less likely to graduate high school in four years than students who never needed to learn English in school. But social identities like race and gender make a difference, and some groups of English learners are actually more likely to graduate, according to a new study by a team of education researchers at NYU and the University of Houston.
For instance, young women who ever learned English in school are more likely to graduate in four years than young men who did not. Similarly, Black English learners tend to have better four-year graduation rates than Black peers who never needed to learn English ...
SwRI’s Herron named 2024 ASSP Safety Professional of the Year
2024-05-06
SAN ANTONIO — May 6, 2024 —The American Society of Safety Professionals (ASSP) has named Southwest Research Institute’s Matthew Herron, M.S., P.E., CSP, CPE, its 2024 Safety Professional of the Year. The award is presented annually to an ASSP member who demonstrates outstanding achievement in the occupational safety and health (OSH) field while also advancing the OSH profession overall.
“It’s a great honor to be recognized by the ASSP as Safety Professional of the Year,” said Herron, a lead safety engineer in SwRI’s Mechanical Engineering Division. “I firmly ...
Long-term cardiovascular outcomes in children and adolescents with hypertension
2024-05-06
About The Study: Children diagnosed with hypertension had a higher associated long-term risk of major adverse cardiac events compared with controls without hypertension. Improved detection, follow-up, and control of pediatric hypertension may reduce the risk of adult cardiovascular disease.
Authors: Rahul Chanchlani, M.B.B.S., M.D., M.Sc., of McMaster University in Hamilton, Canada, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamapediatrics.2024.1543)
Editor’s ...
CRIPSR gene editing leads to improvements in vision for people with inherited blindness, clinical trial shows
2024-05-06
KEY TAKEAWAYS
BRILLIANCE trial results showed 11 out of 14 treated participants experienced some improvements in vision and quality of life measures.
CRISPR-based therapy was found safe with no dose-limiting toxicities reported.
Mass Eye and Ear researchers say their findings support continued research and clinical trials of CRISPR therapies for inherited retinal disorders.
BOSTON- (MAY 6, 2024) Results from a groundbreaking clinical trial of CRISPR gene editing in 14 individuals ...
Improvement seen in most participants of pioneering CRISPR gene editing trial
2024-05-06
PORTLAND, Oregon – About 79% of clinical trial participants experienced measurable improvement after receiving experimental, CRISPR-based gene editing that is designed to fix a rare form of blindness, according to a paper published in the New England Journal of Medicine.
“This trial shows CRISPR gene editing has exciting potential to treat inherited retinal degeneration,” said Mark Pennesi, M.D., Ph.D., a corresponding author on the paper, an ophthalmologist and Oregon Health & Science University’s lead scientist for the Phase ...
Cybersecurity education varies widely in US
2024-05-06
PULLMAN, Wash. -- Cybersecurity programs vary dramatically across the country, a review has found. The authors argue that program leaders should work with professional societies to make sure graduates are well trained to meet industry needs in a fast-changing field.
In the review, published in the Proceedings of the Association for Computing Machinery’s Technical Symposium on Computer Science Education, a Washington State University-led research team found a shortage of research in evaluating the instructional approaches being used to teach cybersecurity. The authors also contend that programs ...
New vaccine effective against coronaviruses that haven’t even emerged yet
2024-05-06
Researchers have developed a new vaccine technology that has been shown in mice to provide protection against a broad range of coronaviruses with potential for future disease outbreaks - including ones we don’t even know about.
This is a new approach to vaccine development called ‘proactive vaccinology’, where scientists build a vaccine before the disease-causing pathogen even emerges.
The new vaccine works by training the body’s immune system to recognise specific regions of eight different coronaviruses, including SARS-CoV-1, SARS-CoV-2, and several that are ...
Simulated chemistry: New AI platform designs tomorrow’s cancer drugs
2024-05-06
Scientists at UC San Diego have developed a machine learning algorithm to simulate the time-consuming chemistry involved in the earliest phases of drug discovery, which could significantly streamline the process and open doors for never-before-seen treatments. Identifying candidate drugs for further optimization typically involves thousands of individual experiments, but the new artificial intelligence (AI) platform could potentially give the same results in a fraction of the time. The researchers used the new tool, described in Nature Communications, to synthesize 32 new drug candidates for cancer.
The technology is part of a new but growing trend ...
Human ‘neural compass’ pinpointed in new study
2024-05-06
A pattern of brain activity that helps prevent us from getting lost has been identified in a new study, published in Nature Human Behaviour.
Researchers at the University of Birmingham and Ludwig Maximilian University of Munich have for the first time been able to pinpoint the location of an internal neural compass which the human brain uses to orientate itself in space and navigate through the environment.
The research identifies finely tuned head direction signals within the brain. The results are comparable to neural codes identified in ...
Personalized screening early in pregnancy may improve preeclampsia detection
2024-05-06
Research Highlights:
A personalized screening algorithm for preeclampsia in the first trimester of pregnancy may help clinicians better predict who is at risk for developing the condition and who may benefit from treatment with a daily, low-dose aspirin.
In this study of more than 7,000 women, the new screening method, which combined maternal history, biomarker tests and ultrasound tests, was better at identifying preeclampsia risk in than current risk factor-based guidelines.
Embargoed until 4 a.m. CT/5 a.m. ET Monday, May 6, 2024
DALLAS, May 6, 2024 — A new screening algorithm for preeclampsia combining maternal history, ...